{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pfam:PF12252",
      "entity_text" : "side",
      "entity_type" : "family"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:5281004",
      "entity_text" : "Budesonide",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Budesonide, a common steroid treatment of Crohn 's disease and ulcerative colitis, has a high affinity for steroid receptors and produces fewer side effects due to its lower systemic impact.",
  "reading_complete" : "2020-08-08T19:02:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:54:25Z",
  "trigger" : "produces",
  "evidence" : [ "Budesonide, a common steroid treatment of Crohn's disease and ulcerative colitis, has a high affinity for steroid receptors and produces fewer side" ],
  "pmc_id" : "5095570",
  "score" : 0
}